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The strain-specific spectrum of liver disease following murine hepatitis virus type 3 (MHV-3) infection is
dependent on inflammatory mediators released by macrophages. Production of nitric oxide (NO) by macro-
phages has been implicated in resistance to a number of viruses, including ectromelia virus, vaccinia virus, and
herpes simplex virus type 1. This study was undertaken to define the role of NO in MHV-3 infection. Gamma
interferon-induced production of NO inhibited growth of MHV-3 in a murine macrophage cell line (RAW
264.7). Viral inhibitory activity was reproduced by the NO donor S-nitroso-N-acetyl-DL-penicillamine (SNAP),
whereas N-acetyl-DL-pencillamine (NAP), an inactive analog of SNAP, had no effect. Electron microscopy
studies confirmed the inhibitory effects of NO on viral replication. Peritoneal macrophages isolated from A/J
mice known to be resistant to MHV-3 produced a fivefold-higher level of NO and higher levels of mRNA
transcripts of inducible NO synthase in response to gamma interferon than macrophages from susceptible
BALB/cJ mice. SNAP inhibited growth of MHV-3 in macrophages from both strains of mice to similar degrees.
In vivo inhibition of NO by N-monomethyl-L-arginine resulted in loss of resistance to MHV-3 in A/J mice. These
results collectively demonstrate a defect in the production of NO in macrophages from susceptible BALB/cJ
mice and define the importance of endogenous NO in resistance to MHV-3 infection in resistant A/J mice.
Nitric oxide (NO) has now been established to be an impor-
tant endogenous messenger molecule in mammals and has
been implicated in a wide range of biological processes, such as
regulation of vasomotor tone, neurotransmission, and host de-
fenses against intracellular pathogens (33). It is synthesized
from L-arginine by a family of complex enzymes known as NO
synthases (NOS), which includes at least three different iso-
forms: neuronal (nNOS, NOS1), inducible (iNOS, NOS2), and
endothelial constitutive (ecNOS, NOS3), originally purified
from neurons, cytokine-activated macrophages, and endothe-
lium, respectively (43). The three NOS isoforms are expressed
in a wide range of cell types and tissues, and a cell may even
express two NOS isoforms. NOS are cytochrome P-450-like
heme proteins which catalyze the NADPH-dependent, five-
electron oxidation of L-arginine to generate NO and L-citrul-
line. The nNOS and ecNOS isoforms are constitutively ex-
pressed and are activated through stimulation of the Ca21-
calmodulin signaling pathway. iNOS is a Ca21-independent,
high-output enzyme whose expression can be stimulated by
cytokines or lipopolysaccharide (LPS) (4) in almost every mu-
rine tissue and cell type over a period of hours. Although, for
reasons as yet unclear, human cells express less iNOS mRNA
in response to cytokines than rodent cells (9), sepsis and “sep-
tic-like” states in humans have been associated with increased
urinary excretion of nitrite, suggesting that in vivo activation of
the L-arginine–NO pathway does occur in humans (10, 15).
Functional characterization of the murine iNOS promoter has
demonstrated a proximal region which interacts with the
NF-kb trans-acting factor and which is critical for LPS-induced
transcription of iNOS, as well as a more distal region involved
in gamma interferon (IFN-g)-stimulated changes in transcrip-
tion (45). IFN-g and LPS also exert their stimulatory effects on
NO synthesis by stabilizing iNOS mRNA transcripts (44).
The induction of an antiviral state by interferons is an early
response to viral infection that is essential for host survival.
IFN-g-induced nitric oxide production by macrophages has
been implicated in resistance to intracellular pathogens, such
as parasites (11, 23, 28, 30, 39), fungi (32), mycobacteria (5, 8),
and more recently viruses, including ectromelia virus (18), vac-
cinia virus (14), and herpes simplex virus type 1 (2). In biolog-
ical systems, NO reacts with oxygen (O2), superoxide (O2
2),
and transition metals, leading to the formation of reactive
products that support additional nitrosative reactions at thiol
groups (38). Iron-sulfur clusters and heme proteins which are
now known to be regulated by NO include membrane, cytoso-
lic, and nuclear proteins involved in signal transduction, cellu-
lar respiration and metabolism, DNA synthesis (19, 20), and
initiation of transcription (20). Although the exact mechanism
by which NO exerts its antiviral action remains unknown, the
multiplicity of its host target enzymes makes it probable that
multiple alterations in host cell proteins are involved. In vac-
cinia virus infection of RAW 264.7 cells, NO has been shown
to inhibit viral DNA synthesis, late protein synthesis, and virus
particle formation (14).
We wished to study the role of NO in a murine model of
fulminant viral hepatitis. Murine hepatitis virus strain 3
(MHV-3), a single-stranded positive-sense RNA coronavirus,
induces a strain-specific pattern of disease in inbred laboratory
mice, which has served as an extremely useful experimental
model for the study of host resistance/susceptibility to human
fulminant viral hepatitis. Susceptible inbred mouse strains,
such as BALB/c or C57BL/6, develop fulminant hepatitis and
die within 3 to 5 days following parenteral inoculation of the
virus. In contrast, A/J mice are resistant, develop no clinical
signs of hepatitis, and clear the virus within 10 days of infection
(3). As the virus grows in both susceptible and resistant mice
(27), we have previously suggested that differences in the host
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inflammatory response account for resistance/susceptibility to
MHV-3 (3, 21). A pivotal role for IFN-g in murine viral hep-
atitis was suggested with the finding that treatment of A/J mice
with anti-IFN-g serum rendered them susceptible to MHV-3-
induced disease (24). Furthermore, macrophages from resis-
tant mice but not those from susceptible mice are able to
restrict the growth of MHV-3 when activated with IFN-g (29,
35).
The present study demonstrated that IFN-g-induced pro-
duction of NO inhibits the growth of MHV-3 in RAW 264.7
cells and that IFN-g-activated macrophages from resistant A/J
mice produce greater amounts of NO and are able to restrict
viral replication to a greater degree than macrophages from
IFN-g-activated susceptible BALB/cJ mice. Furthermore,
treatment of A/J mice with N-monomethyl-L-arginine (L-
NMMA), an inhibitor of NO synthesis, increases mortality
following MHV-3 infection, demonstrating the importance of
NO production in resistance to MHV-3 in vivo.
MATERIALS AND METHODS
Mice. Eight- to twelve-week-old female BALB/cJ and A/J mice were obtained
from Jackson Laboratory (Bar Harbor, Maine). They were housed in microiso-
lator cages and fed a standard chow and water ad libitum. Random mice were
tested, and were all seronegative for routine viruses, including MHV.
Virus. MHV-3 was plaque purified on DBT cells and grown to a titer of 107
PFU/ml in 17CL1 cells (22). Viral titers were tested in a standard plaque assay
on monolayers of L2 cells as previously described (21). The origin and growth of
17CL1, DBT, and L2 cells have been described elsewhere (16, 40).
Cells. RAW 264.7 cells (ATCC TIB71), a murine macrophage cell line trans-
formed with the Abelson leukemia virus (37), were propagated in Dulbecco
modified Eagle medium (ICN Biomedicals Inc., Costa Mesa, Calif.) containing
400 mM L-arginine, buffered with 16 mM MOPS [(N-morpholino)propane sul-
fonic acid] -HEPES-TES [N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic
acid] (Sigma Chemical Co., St. Louis, Mo.)–0.3% sodium bicarbonate and sup-
plemented with 2 mM glutamine (Sigma), 100 U each of penicillin and strep-
tomicin per ml, and 10% heat-inactivated fetal calf serum (Flow Laboratories,
Mississauga, Ontario, Canada) (ADME-10). Peritoneal macrophages were ob-
tained by lavage of the peritoneal cavity with 10 ml of RPMI 1640 (ICN Bio-
medicals) supplemented with 2 mM glutamine 4 days after intraperitoneal (i.p.)
administration of 1.5 ml of 3% thioglycolate (Difco Laboratories, Detroit, Mich.)
as previously described (21).
The cells were washed once and suspended in ADME-2 at 5 3 105/ml (2
ml/well) in six-well plates (Corning Glass Works, Corning, N.Y.). Two hours
later, the nonadherent cells were removed and the adherent cells were infected
with 1,000 PFU of MHV-3 (multiplicity of infection [MOI] of 0.001). After viral
adsorption for 30 min at 22°C, 2 ml of ADME-2 with or without other reagents
was added per well and the cells were incubated at 37°C; 24 to 48 h later, the cells
were scraped off and stored at 270°C until viral titers and nitrite levels were
measured.
Reagents. S-Nitroso-N-acetyl-DL-penicillamine (SNAP; Alexis Corporation,
San Diego, Calif.) was reconstituted in methanol at a concentration of 250 to 500
mM prior to use. At these concentrations, SNAP was not toxic to RAW cells,
whereas at a concentration of 750 mM or greater, significant toxicity was seen.
N-Acetyl-DL-penicillamine (NAP; Sigma) was reconstituted in methanol at a
concentration of 250 to 500 mM prior to use. Recombinant murine IFN-g
(Pharmingen, San Diego, Calif.) was reconstituted in ADME-2. L-NMMA (Sig-
ma) was dissolved in phosphate-buffered saline (PBS) and filter sterilized. The
Griess reagent (11) was prepared fresh for each experiment by mixing equal
amounts of 0.1% N-(1-naphthyl)ethylenediamine dihydrochloride (Sigma) in
water and 1% sulfanilamide (Sigma) in 5% phosphoric acid. The two constitu-
ents were stored at 4°C in dark bottles.
Nitrite assay. Freeze-thawed samples were centrifuged at 300 3 g for 10 min;
100-ml aliquots of the supernatants were then mixed with an equal volume of
Griess reagent (see above) and incubated for 10 min at 37°C. The optical density
at 540 nm was determined on an automated multiscan spectrophotometer (Flow
Laboratories). The nitrite concentration was determined by using sodium nitrite
(Sigma) as a standard for each experiment. The absorbance of medium alone was
subtracted from the value obtained for each sample.
Northern blotting. After appropriate treatment, peritoneal macrophages from
A/J and BALB/cJ mice were washed with PBS, pelleted, and frozen in liquid
nitrogen. Total RNA was isolated by 8 M acid-guanidinium hydrochloride ex-
traction in a modified procedure described by Evans and Kamdar (6). The
amount and purity of RNA were quantified by measuring the optical densities at
260 and 280 nm in a Spectronic 1001 spectrophotometer (Bausch & Lomb), and
15 mg of total RNA was added per lane. RNA was resolved on a 0.8% agarose
gel containing MOPS-formaldehyde and transferred onto a nitrocellulose mem-
brane (Schleicher & Schuell, Keene, N.H.). Forty nanograms of a cDNA probe
for murine iNOS (26) was labeled by using a random priming DNA labeling
system (Pharmacia Inc., Montreal, Quebec, Canada) with [a-32P]dCTP (specific
activity, .3,000 Ci/mmol; Amersham, Mississauga, Ontario, Canada) to a spe-
cific activity of 4 3 108 cpm/mg. Membranes were prehybridized for 5 h at 42°C
in a mixture of 50% formamide, 53 Denhardt’s solution, 0.2% sodium dodecyl
sulfate, 100 mg of denatured salmon sperm DNA per ml, and 53 SSPE buffer
(13 SSPE is 0.18 M NaCl, 10 mM NaH2PO4, and 1 mM EDTA [pH 7.7]).
Hybridization was carried out overnight in the same mixture at 42°C. The mem-
branes were then washed under medium-stringency conditions and exposed to
Kodak XAR-5 film with intensifying screens for 24 h at 270°C. To confirm the
integrity and amount of RNA added to each lane, the membrane was reprobed
with a human glyceraldehyde-3-phosphate dehydrogenase cDNA probe (42).
Electron microscopy. After aspiration of the medium, RAW 264.7 cells which
had been infected with MHV-3 at an MOI of 2.5 for 24 h, to ensure that 100%
of cells were infected, in the presence or absence of IFN-g or SNAP were fixed
for 30 min with PBS containing 2.5% glutaraldehyde at 4°C and postfixed in 1%
osmic acid in cacodylate buffer. Dehydration in acetone was followed by embed-
ding in epoxy resin. Thin sections were stained with 2% aqueous uranyl acetate
followed by lead citrate. The sections were examined in a Philips 400 electron
microscope at 60 kV.
Statistical analysis. Data are expressed as means 61 standard deviation (SD)
where applicable. Student’s t test for unpaired samples (two tailed) was used to
analyze the data. The effect of L-NMMA treatment on survival in MHV-3-
infected A/J mice was analyzed by survival analysis using the Kaplan-Meier
method.
RESULTS
Effect of SNAP on growth of MHV-3 in macrophages. The
addition of SNAP, an NO donor (7), to RAW 264.7 cells
inhibited the growth of MHV-3 (Fig. 1A), whereas the vehicle
control had no effect. The inhibition was not due to toxic
effects on RAW 264.7 cells, as demonstrated by trypan blue
staining. In additional studies, using peritoneal macrophages
from both A/J and BALB/cJ mice, SNAP inhibited MHV-3
replication to a similar degree. In contrast, NAP had no inhib-
itory effects on viral replication (Fig. 1B and C).
To determine whether SNAP directly affected viral infectiv-
ity, MHV-3 was incubated with SNAP for 45 min on ice and
then assayed on monolayers of L2 cells. Levels of replication of
virus were equivalent in the presence and absence of SNAP
(data not shown).
Effects of IFN-g and L-NMMA on MHV-3 replication. Re-
combinant murine IFN-g induced NO production and re-
stricted viral replication in RAW 264.7 cells in a concentration-
dependent fashion over the range 0.1 to 10 U/ml (Fig. 2). The
addition of L-NMMA at a concentration of 1,000 mM in com-
bination with IFN-g at 10 U/ml resulted in inhibition of nitrite
production by 88% and a significant (1,000-fold) increase
in peak viral titers compared to that with IFN-g alone (two-
tailed P value 5 0.01). The addition of L-arginine (6 mM)
completely reversed the inhibitory effect of L-NMMA (Fig. 3).
Effects of IFN-g and SNAP on viral particle formation in
RAW 264.7 macrophages. RAW 264.7 cells infected with
MHV-3 for 24 h showed evidence of cell damage, particularly
in the presence of numerous cytoplasmic vacuoles which oc-
cupied large areas of the cell cytoplasm (Fig. 4); few vacuoles
only were seen in the noninfected controls (not shown). The
clusters of small particles seen free in the cytoplasm outside
the vacuoles are ribosomes. Numerous viral particles (virions)
were seen within the cytoplasmic vacuoles of the infected cells.
These were spheroidal and had an electron-dense core and the
typical overall structure of coronaviruses. The sizes of viruses
in this family vary from 80 to 160 nm (17); the ones illustrated
in Fig. 4 range from 75 to 125 nm. They were very numerous in
the MHV-3-infected nontreated group (Fig. 4A), less frequent
in the MHV-3-infected interferon-treated cells (Fig. 4B), and
undetectable in the MHV-3-infected, SNAP-treated group
(Fig. 4C). In the MHV-infected, SNAP-treated cells, we found
(Fig. 4C) very small, uniform, electron-dense particles (ap-










proximately 18 nm) which were not seen in the other groups;
they may represent viral protein.
Effects of IFN-g and L-NMMA on NO production and
MHV-3 replication in peritoneal macrophages. A/J macro-
phages produced significantly higher levels of nitrite than
BALB/cJ macrophages in response to IFN-g at all concentra-
tions studied (10 to 1,000 U/ml) (Fig. 5A). Northern blot hy-
bridization revealed higher steady-state iNOS mRNA levels
following activation with IFN-g in A/J than in BALB/cJ mac-
rophages (Fig. 5C). No iNOS mRNA transcripts were detected
in either A/J or BALB/cJ macrophages infected with MHV-3
for 8 h.
IFN-g at doses of 10 to 1,000 U/ml, added immediately
following viral adsorption, significantly inhibited peak viral
growth in A/J macrophages only, not in BALB/cJ macro-
phages, with maximum inhibition at 100 U/ml and no further
inhibition even at 1,000 U/ml (P 5 0.01), as seen in Fig. 5B.
The addition of L-NMMA at a concentration of 1,000 mM only
partly reversed the antiviral action of IFN-g in A/J macro-
phages, despite inhibiting NO production by 93% (not shown).
Although no iNOS mRNA transcripts were detected in peri-
toneal macrophages infected with MHV-3 for 8 h (Fig. 5C),
low (,10 mM) levels of nitrite were measured after MHV-3
infection of RAW 264.7 cells and A/J peritoneal macrophages
for 48 h (Fig. 5A).
Effect of L-NMMA on resistance of A/J mice to MHV-3. The
importance of endogenous NO production in host resistance
following MHV-3 infection in vivo was next examined. As
shown in Fig. 6, treatment of A/J mice with L-NMMA (4
mg/day/mouse i.p.) for 2 weeks following infection with
MHV-3 (10 PFU i.p.) resulted in 50% mortality. The liver
pathology was consistent with fulminant hepatitis with wide-
spread fibrin deposition and hepatocellular necrosis as is seen
in susceptible BALB/cJ mice. None of the animals that re-
ceived MHV-3 or L-NMMA alone died. The mean survival
time in the group receiving both L-NMMA and MHV-3 was
10.38 days (95% confidence interval [CI], 7.85 to 12.90 days;
determined by Kaplan-Meier survival analysis) and was thus
FIG. 1. SNAP specifically inhibits MHV-3 replication in RAW 264.7 (A), A/J
(B), and BALB/cJ (C) macrophages. We infected 106 macrophages with 1,000
PFU of MHV-3 (MOI of 0.001) in the presence or absence of 500 mM SNAP or
500 mM NAP for 24 h. SNAP, NAP, and the control vehicle, 0.5% methanol,
were added every 4 h. Viral titers were measured by plaque assay. The control
vehicle had no effect (not shown). Each bar represents the mean 6 SD of the
results from four independent experiments. Viral titers were compared by an
unpaired t test (p, two-tailed P value , 0.05).
FIG. 2. IFN-g inhibits MHV-3 replication and induces NO production in
RAW 264.7 cells. We infected 106 RAW 264.7 macrophages with 1,000 PFU of
MHV-3 (MOI of 0.001) in the presence or absence of IFN-g at doses ranging
from 0.1 to 10 U/ml. Viral titers and nitrite levels were measured after 48 h.
Values are means 6 SDs of results from three separate experiments.
FIG. 3. L-NMMA blocks IFN-g-induced inhibition of viral replication and
NO production in RAW 264.7 cells. We infected 106 RAW 264.7 macrophages
with 1,000 PFU of MHV-3 (MOI of 0.001) in the presence or absence of IFN-g
(10 U/ml), with and without L-NMMA (1,000 mM) and L-arginine (L-Arg; 6 mM),
as shown. Viral titers (`) and nitrite levels (o) were measured after 48 h.
Values are means 6 SDs of results from three separate experiments.










significantly shorter than in either control group, where all
animals survived for 14 days.
DISCUSSION
These studies demonstrate a linkage between NO produc-
tion and genetic resistance to MHV-3 infection both in vivo
and in vitro. Although NO production or lack of production
has been implicated in the pathogenesis of a number of dis-
eases (8, 12, 23, 28, 30, 32, 39, 41, 46), this is the first demon-
stration of a strain-dependent difference in the production of
NO and resistance to a viral pathogen and explains the inter-
feron nonresponsiveness of BALB/cJ mice.
In a previous study, we reported that the pattern of disease
after MHV-3 infection correlated with macrophage activation
and not viral replication (36). Macrophages from susceptible
BALB/cJ mice following MHV-3 infection produced greater
amounts of interleukin 1, tumor necrosis factor alpha, leuko-
triene B4, and a unique cellular procoagulant with prothrom-
binase activity than macrophages from resistant A/J mice. In
the present study, we focus on the role of NO in resistance and
susceptibility to MHV-3 infection.
The addition of SNAP, an NO donor, to RAW 264.7 cells
and peritoneal macrophages from both resistant A/J and sus-
ceptible BALB/cJ mice inhibited the growth of MHV-3. This
antiviral effect was specific, as demonstrated by the fact that
NAP, an inactive analog of SNAP, had no inhibitory effects,
and furthermore was not due to toxic effects on macrophages,
as SNAP did not affect cell viability. Croen (2) also showed that
SNAP, at a concentration of 500 mM added every 4 h, did not
cause cell death, although it inhibited DNA and protein syn-
thesis in RAW 264.7 cells to a degree similar to that effected by
IFN-g and LPS used in combination. Mammalian cells utilize
several defense mechanisms against oxidant stress, including
manganese-specific superoxide dismutase, glucose-6-phos-
phate dehydrogenase, and glutathione S-transferase, which are
all activated following cytokine activation of macrophages (38).
Thus, although NO does not appear to be directly toxic to
FIG. 4. Electron micrographs of RAW 264.7 mouse macrophages infected with MHV-3 for 24 h. Cytoplasmic vacuoles in the periphery of cultured cells are shown.
(A) MHV-3. Note spherical virions measuring 75 to 125 nm (arrowheads) within vacuoles. The electron-dense nucleocapsid is visible within many of the virions. These
virions are typical of coronaviruses. (B) MHV-3 plus IFN-g. The findings are similar to those in panel A, but there are fewer virions. Note also spherical virions adherent
to the cell membrane (arrowheads). (C) MHV-3 plus SNAP. No virions are seen. The small dense particles (approximately 18 nm in diameter; arrowheads) may be
viral protein. (Magnification, 355,000).










MHV-3 virions or the host macrophages, it produces changes
in host macrophages that interfere with viral replication, likely
through effects on a multiplicity of target enzymes (18). The
electron microscopy studies using MHV-3-infected RAW
264.7 cells demonstrate that NO is a potent inhibitor of viral
particle formation and that it can reproduce the antiviral ac-
tion of IFN-g.
Furthermore, IFN-g inhibited the growth of MHV-3 in
RAW 264.7 cells in part through inducing NO production, as
demonstrated by the increase in viral titers concomitant with
inhibition of nitrite synthesis seen in the presence of L-NMMA.
L-Arginine, the substrate of NOS, reversed the inhibitory of
effect of L-NMMA. The fact that the inhibitory effect of IFN-g
was only partly reversed by L-NMMA indicates that at this dose
(10 U/ml), IFN-g must exert its antiviral action through other
mechanisms as well, such as the induction of phosphatidylino-
sitol kinase, 2959-oligoadenylate synthetase, indoleamine 2,3-
dioxygenase, Mx proteins, 9-27 protein, and other, as yet un-
known, mechanisms (18). In support of this, Harris et al. (14)
also found that at high doses of IFN-g, L-NMMA does not
produce an increase in viral titers, suggesting that NO produc-
tion is not the only pathway mediating the antiviral action of
IFN-g.
Macrophages from resistant A/J mice treated with IFN-g (10
to 1,000 U/ml) produced higher levels of iNOS mRNA tran-
scripts and higher levels of nitrite than macrophages from
susceptible BALB/cJ mice. IFN-g, at all concentrations stud-
ied, significantly inhibited the growth of MHV-3 in macro-
phages from resistant A/J mice, with maximum inhibition at a
concentration of 100 U/ml. In contrast, no significant inhibition
was seen in macrophages from susceptible BALB/cJ mice
treated with IFN-g. The relatively poor inhibition of the
growth of MHV-3 in A/J macrophages compared to RAW
264.7 cells is consistent with the lower levels of nitrite induced
by IFN-g in A/J macrophages than in RAW 264.7 cells. It is
also in agreement with other reports stating that multiple co-
stimulatory signals are required for both effective synthesis of
NO and induction of macrophage microbicidal activity (31).
Our data are consistent with the observations of Pereira and
colleagues (25, 29), who have demonstrated that macrophages
from A/J but not BALB/cJ mice are able to restrict the growth
of MHV-3 in response to IFN-g. Recently, we have shown that
A/J mice produce significantly higher concentrations of IFN-g
than BALB/cJ mice following MHV-3 infection in vivo (34).
Thus, the data in this report provide an explanation, a differ-
ence in response to IFN-g rather than production of IFN-g.
We have recently shown that following infection with
MHV-3, A/J mice generate a Th1 T-helper cell response,
known to be associated with the production of IFN-g (1, 34).
Treatment of A/J mice with anti-IFN-g serum has been re-
ported to lead to loss of resistance to MHV-3 infection (24).
Our studies extend these observations by the demonstration
that blocking NO production in vivo by treating mice with
FIG. 5. (A) IFN-g induces greater NO production in A/J than in BALB/cJ
macrophages. We treated 106 macrophages from susceptible BALB/cJ or resis-
tant A/J mice with IFN-g (100 U/ml) for 48 h. Nitrite levels were measured by a
colorimetric assay using the Griess reagent. The experiment was done three
times in triplicate wells. Values are means 6 SDs of results from three separate
experiments. (B) IFN-g significantly inhibits MHV-3 replication in A/J macro-
phages only. We infected 106 macrophages from susceptible BALB/cJ or resis-
tant A/J mice with 1,000 PFU of MHV-3 in the presence or absence of IFN-g
(100 U/ml). Viral titers were measured after 48 h, and percent inhibition of viral
replication was calculated by using the following formula: (viral titer in control
sample 2 viral titer in study sample)/(viral titer in control sample) 3 100. Values
are means 6 SDs of results from three separate experiments. (C) IFN-g induces
greater iNOS mRNA expression in A/J than in BALB/cJ macrophages. We
infected 106 macrophages from susceptible BALB/cJ mice (lanes 1 to 4) or
resistant A/J mice (lanes 5 to 8) with 1,000 PFU of MHV-3 in the presence (lanes
3 and 7) or absence (lanes 2 and 6) of IFN-g (100 U/ml) or treated them with
IFN-g (100 U/ml) alone (lanes 4 and 8). Lanes 1 and 5 contain unstimulated
macrophages. Following incubation for 8 h, total RNA was extracted and 15 mg
was added per lane. The RNA was separated on an agarose gel, transferred to a
nitrocellulose membrane, and probed with an iNOS cDNA probe. A glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) cDNA probe was used to ensure
equal loading of all lanes.
FIG. 6. L-NMMA causes partial loss of resistance to MHV-3. Resistant A/J
mice were infected with 10 PFU of MHV-3 i.p. and treated daily with L-NMMA
(4 mg/day i.p.) for 14 days (n 5 8). Control mice were either infected with 10
PFU of MHV-3 i.p. (n 5 7) or treated with L-NMMA (4 mg/day i.p.) (n 5 7) for
14 days. Mean survival times and 95% CI in each group were calculated by
survival analysis using the Kaplan-Meier method. p, mean survival time in this
group was 10.38 days, and the upper limit of the 95% CI was 12.9 days.










L-NMMA, a nontoxic competitive inhibitor of L-arginine, also
causes loss of resistance of A/J mice to MHV-3 infection,
resulting in severe hepatocellular necrosis and fibrin deposi-
tion similar to the pathology of susceptible BALB/cJ mice.
Thus, in vivo the production of NO is a critical mediator of the
antiviral action of IFN-g, although we have not excluded other
possible protective effects of NO, such as vasomotor effects or
modulation of T-helper cell differentiation. Treatment with
L-NMMA has been shown to increase mortality in another
model of fulminant hepatitis induced by corynebacterium-LPS,
and it was suggested that endogenous NO production may
exert a beneficial vasodilator effect on the hepatic microcircu-
lation (13). Thus, although NO has a direct inhibitory effect on
viral replication in macrophages in vitro, it will be important in
future studies to determine whether this is the only mechanism
by which it exerts its protective effect in vivo. In a model of
virus-induced interstitial pneumonitis, production of cytokines
such as tumor necrosis factor alpha also accounted for disease,
whereas in contrast to the MHV-3 model of fulminant hepatic
failure, production of NO provoked and aggravated the inter-
stitial pneumonitis (41). Thus, it is apparent that production of
NO is protective in some disease states but deleterious in
others.
This study demonstrates the importance of NO production
in resistance to fulminant viral hepatitis caused by MHV-3.
The correlation between NO production in response to IFN-g
and host resistance to viral hepatitis is of potentially great
interest for the elucidation of mechanisms of host resistance/
susceptibility to viral pathogens. Furthermore, it should pro-
vide for the future development of effective antiviral therapy.
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